This study aims to develop and validate a novel Turkish-language self-report instrument, the Kinesiophobia Severity Scale in Urinary Incontinence (KSS-UI), to assess movement avoidance and fear of movement associated with concerns about urinary leakage in individuals with urinary incontinence. Following scale development, its validity and reliability will be evaluated through psychometric analyses in accordance with the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) recommendations.
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Being 18 years of age or older
* Reporting symptoms of incontinence at least once a week for the past 3 months (ICIQ-SF score ≥ 1)
* Having the ability to read and comprehend Turkish
* Having been informed about the study and provided written informed consent
Exclusion Criteria:
* Having an active lower urinary tract infection
* Inability to complete the scales independently due to cognitive impairment, advanced dementia, or limited literacy
* Individuals who refuse to participate in the study or do not sign the informed consent form
Primary outcome measure(s)
Content Validity of the Kinesiophobia Severity Scale in Urinary Incontinence (KSS-UI) — During the initial expert evaluation, before participant recruitment for the main validation study. The content validity of the newly developed scale will be evaluated by a multidisciplinary panel of at least 10 experts. Item relevance, clarity, simplicity, and necessity will be assessed using the Content Validity Ratio (CVR), Item-level Content Validity Index (I-CVI), Scale-level Content Validity Index (S-CVI), and modified kappa statistics.
Trial sites (1)
Facility
City
Region
Status
Kırşehir Ahi Evran Üniversitesi
Kırşehir
Kırşehir
Recruiting
More Ahi Evran University Education and Research Hospital trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.